Operating Lease, Liability of Nurix Therapeutics, Inc. from 28 Feb 2022 to 30 Nov 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Nurix Therapeutics, Inc. quarterly Operating Lease, Liability in USD history and change rate from 28 Feb 2022 to 30 Nov 2024.
Nurix Therapeutics, Inc. Operating Lease, Liability for the quarter ending 30 Nov 2024 was $28,303,000, a 7.5% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$28,303,000	-$2,311,000	-7.5%	30 Nov 2024	10-K	28 Jan 2025	2024	FY
Q4 2023	$30,614,000	+$18,650,000	+156%	30 Nov 2023	10-K	15 Feb 2024	2023	FY
Q4 2022	$11,964,000			30 Nov 2022	10-K	09 Feb 2023	2022	FY
Q3 2022	$13,241,000			31 Aug 2022	10-Q	06 Oct 2022	2022	Q3
Q2 2022	$14,513,000			31 May 2022	10-Q	07 Jul 2022	2022	Q2
Q1 2022	$15,756,000			28 Feb 2022	10-Q	08 Apr 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.